Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Codexis (CDXS) Shares Outstanding (Diluted Average) (2016 - 2025)

Codexis (CDXS) has 12 years of Shares Outstanding (Diluted Average) data on record, last reported at $87.1 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 18.71% year-over-year to $87.1 million; the TTM value through Dec 2025 reached $87.1 million, up 18.71%, while the annual FY2025 figure was $87.1 million, 18.71% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $87.1 million in Q4 2025 per CDXS's latest filing, up from $86.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $87.1 million in Q4 2025 and bottomed at $64.3 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $70.7 million, with a median of $67.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 1.2% in 2022, then increased 21.33% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $64.6 million in 2021, then rose by 1.2% to $65.3 million in 2022, then grew by 4.27% to $68.1 million in 2023, then grew by 7.75% to $73.4 million in 2024, then grew by 18.71% to $87.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $87.1 million in Q4 2025, $86.0 million in Q3 2025, and $85.4 million in Q2 2025.